About Luzitin

Photodynamic therapy

Research & Development

For Patients and Health Professionals

Partners and Investors

Why you should select Luzitin?

Luzitin, S.A. is a pharmaceutical company focused on the pursuit of innovative solutions for photodynamic therapy (PDT) and photodiagnosis (PDD).

Latest Publications

Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report

Santos L, L, Oliveira J, Monteiro E, Santos J, Sarmento C
Case Rep Oncol 2018;11:769-776

A first in human study using photodynamic therapy with Redaporfin in advanced head and neck cancer

Julio Oliveira, Eurico Monteiro, Juliana Santos, Jose Dinis Silva, Luis Almeida, Lúcio Lara Santos
J Clin Oncol 35, 2017 (suppl; abstr e14056)

Ultrafast Dynamics of Manganese(III), Manganese(II), and Free-Base Bacteriochlorin: Is There Time for Photochemistry?

Fabio A. Schaberle, Artur R. Abreu, Nuno P. F. Gonçalves, Gonçalo F. F. Sá, Mariette M. Pereira, and Luís G. Arnaut
Inorg. Chem., 2017, 56 (5), pp 2677–2689.

More publications

Bluepharma
Universidade de Coimbra
Portugal Ventures
Compete2020
Portugal2020
União Europeia